Table 2.
The relationship between the expression of PVT1 and clinicopathological features of GC patients.
| Group | n | Han | P | n | Uygur | P | |||
|---|---|---|---|---|---|---|---|---|---|
| negative | positive | negative | positive | ||||||
| Sex | male | 7 | 3 | 4 | 0.559 | 10 | 5 | 5 | 1.000 |
| female | 7 | 1 | 6 | 5 | 2 | 3 | |||
| Age (years) | ≤55 | 6 | 1 | 5 | 0.580 | 4 | 3 | 1 | 0.282 |
| ➢55 | 8 | 3 | 5 | 11 | 4 | 7 | |||
| T | T1−2 | 3 | 3 | 0 | 0.033 | 2 | 1 | 1 | 1.000 |
| T3–4 | 11 | 1 | 10 | 13 | 6 | 7 | |||
| N | N0 | 4 | 3 | 1 | 0.041 | 6 | 5 | 1 | 0.041 |
| N1−3 | 10 | 1 | 9 | 9 | 2 | 7 | |||
| Stage | I II | 3 | 2 | 1 | 0.176 | 6 | 5 | 1 | 0.041 |
| III IV | 11 | 2 | 9 | 9 | 2 | 7 | |||
| Histopathological grade | Well + Moderately differentiated | 6 | 2 | 4 | 1.000 | 6 | 1 | 5 | 0.119 |
| Poorly differentiated | 8 | 2 | 6 | 9 | 6 | 3 | |||
Note: aFisher’s exact probability test. T: the primary tumor site; N: the involvement of regional lymph nodes; M: the presence of distant metastases; *P < 0.05.